Hanx Bio Announces 1st Dosing in Ph 1 Clinical Trial of HX044
02 Jan 2025 //
PR NEWSWIRE
Crown Bioscience, HanX pact shows promise of lymphoma drug
24 Aug 2023 //
FIERCE BIOTECH
Crown Bio Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
22 Aug 2023 //
BUSINESSWIRE
China-based HanX earns FDA greenlight for US lymphoma trial
23 May 2023 //
CLINICAL TRIALS ARENA
HanX Biopharmaceuticals announces HX009 IND approval from FDA
22 May 2023 //
PR NEWSWIRE